Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ocular Therapeutix (OCUL) Change in Inventory: 2014-2025

Historic Change in Inventory for Ocular Therapeutix (OCUL) over the last 12 years, with Sep 2025 value amounting to $449,000.

  • Ocular Therapeutix's Change in Inventory rose 416.20% to $449,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 million, marking a year-over-year increase of 631.76%. This contributed to the annual value of $735,000 for FY2024, which is 122.05% up from last year.
  • Ocular Therapeutix's Change in Inventory amounted to $449,000 in Q3 2025, which was up 295.22% from -$230,000 recorded in Q2 2025.
  • Over the past 5 years, Ocular Therapeutix's Change in Inventory peaked at $635,000 during Q4 2024, and registered a low of -$230,000 during Q2 2025.
  • Its 3-year average for Change in Inventory is $137,636, with a median of $53,000 in 2023.
  • As far as peak fluctuations go, Ocular Therapeutix's Change in Inventory spiked by 1,432.14% in 2022, and later tumbled by 751.85% in 2025.
  • Ocular Therapeutix's Change in Inventory (Quarterly) stood at $28,000 in 2021, then surged by 1,432.14% to $429,000 in 2022, then slumped by 88.81% to $48,000 in 2023, then spiked by 1,222.92% to $635,000 in 2024, then surged by 416.20% to $449,000 in 2025.
  • Its Change in Inventory was $449,000 in Q3 2025, compared to -$230,000 in Q2 2025 and $229,000 in Q1 2025.